163 related articles for article (PubMed ID: 2992940)
1. Specific transforming potential of oncogenes encoding protein-tyrosine kinases.
Mathey-Prevot B; Baltimore D
EMBO J; 1985 Jul; 4(7):1769-74. PubMed ID: 2992940
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
Reddy EP; Smith MJ; Srinivasan A
Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert.
Bergold PJ; Blumenthal JA; D'Andrea E; Snyder HW; Lederman L; Silverstone A; Nguyen H; Besmer P
J Virol; 1987 Apr; 61(4):1193-202. PubMed ID: 3029415
[TBL] [Abstract][Full Text] [Related]
4. Transforming potential of a human protooncogene (c-fps/fes) locus.
Sodroski JG; Goh WC; Haseltine WA
Proc Natl Acad Sci U S A; 1984 May; 81(10):3039-43. PubMed ID: 6328490
[TBL] [Abstract][Full Text] [Related]
5. Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo.
Feuerman MH; Davis BR; Pattengale PK; Fan H
J Virol; 1985 Jun; 54(3):804-16. PubMed ID: 2987532
[TBL] [Abstract][Full Text] [Related]
6. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.
Sadowski I; Stone JC; Pawson T
Mol Cell Biol; 1986 Dec; 6(12):4396-408. PubMed ID: 3025655
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three recombinant murine leukemia viruses carrying the v-src oncogene of avian sarcoma virus: differences in in vitro transformation and in vivo pathogenicity.
Feuerman MH; Lee WT; Pattengale PK; Fan H
Mol Carcinog; 1988; 1(1):57-66. PubMed ID: 2855603
[TBL] [Abstract][Full Text] [Related]
8. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
Rees-Jones RW; Goff SP
J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
[TBL] [Abstract][Full Text] [Related]
9. Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.
Watanabe SM; Witte ON
J Virol; 1983 Mar; 45(3):1028-36. PubMed ID: 6300444
[TBL] [Abstract][Full Text] [Related]
10. Abelson murine leukemia virus: structural requirements for transforming gene function.
Srinivasan A; Dunn CY; Yuasa Y; Devare SG; Reddy EP; Aaronson SA
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5508-12. PubMed ID: 6291048
[TBL] [Abstract][Full Text] [Related]
11. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
Prywes R; Foulkes JG; Rosenberg N; Baltimore D
Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the Abelson murine leukemia virus transforming gene.
Wang JY; Prywes R; Baltimore D
Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes.
Hampe A; Laprevotte I; Galibert F; Fedele LA; Sherr CJ
Cell; 1982 Oct; 30(3):775-85. PubMed ID: 6183005
[TBL] [Abstract][Full Text] [Related]
14. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.
Clark SS; Chen E; Fizzotti M; Witte ON; Malkovska V
J Virol; 1993 Oct; 67(10):6033-46. PubMed ID: 8396667
[TBL] [Abstract][Full Text] [Related]
15. Structure and origins of the HZ2-feline sarcoma virus.
Bergold PJ; Wang JY; Hardy WD; Littau V; Johnson E; Besmer P
Virology; 1987 Jun; 158(2):320-9. PubMed ID: 2884777
[TBL] [Abstract][Full Text] [Related]
16. A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.
Witte ON; Goff S; Rosenberg N; Baltimore D
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4993-7. PubMed ID: 6254050
[TBL] [Abstract][Full Text] [Related]
17. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
Engelman A; Rosenberg N
Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
[TBL] [Abstract][Full Text] [Related]
18. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide sequence and topography of chicken c-fps. Genesis of a retroviral oncogene encoding a tyrosine-specific protein kinase.
Huang CC; Hammond C; Bishop JM
J Mol Biol; 1985 Jan; 181(2):175-86. PubMed ID: 3879969
[TBL] [Abstract][Full Text] [Related]
20. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
